HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathan Werner Selected Research

AMG 337

10/2019Clinical Implications and Translation of an Off-Target Pharmacology Profiling Hit: Adenosine Uptake Inhibition In Vitro.
1/2016In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathan Werner Research Topics

Disease

4Neoplasms (Cancer)
01/2021 - 01/2016
2Alzheimer Disease (Alzheimer's Disease)
06/2017 - 06/2015
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1Headache (Headaches)
10/2019
1Hypotension (Low Blood Pressure)
10/2019
1Oncogene Addiction
01/2016
1Autoimmune Diseases (Autoimmune Disease)
09/2015

Drug/Important Bio-Agent (IBA)

2AMG 337IBA
10/2019 - 01/2016
1LigandsIBA
01/2021
1AMG 757IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
11/2019
1Cysteine (L-Cysteine)FDA Link
11/2019
1Theophylline (Theon)FDA LinkGeneric
10/2019
1CoffeeFDA Link
10/2019
1Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2019
1Adenosine (Adenocard)FDA LinkGeneric
10/2019
1XanthenesIBA
06/2017
1Phosphotransferases (Kinase)IBA
01/2016
1CytokinesIBA
09/2015
1Peptides (Polypeptides)IBA
09/2015
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
06/2015

Therapy/Procedure

1Therapeutics
06/2017